Q2 2020

GHP / Q2 2020 23 , Feb20512 Mastering Pain Management Chronic painmanagement is an essential, and evolving, science, withmany companies exploring new andmore effective ways of dispensing it. The teamat DyAnsys are leaders in the field, proving to be worthy winners in the Biotechnology Awards 2020. Having scooped the prestigious titles of Leading Innovators inNon-Narcotic Pain Treatments – USA and Pioneers in Experimental RCT Solutions 2020, we lookmore closely at this impressive team to find out more. When it comes to pain management, the need for unique solutions has become increasingly apparent. The team at DyAnsys have become experts in the field, focusing specifically on the Autonomic Nervous System (ANS). Through exclusive and extensive research, the company has developed its own unique insight into the treatment of chronic pain. The result for consumers can be lifechanging, with products that have been developed, manufactured and distributed to the highest possible standards in order to meet the needs of the ANS. As this aspect of the body has become increasingly recognized for its importance to wellness and fitness, the team’s targeted approach is able to open doors that had previously been firmly shut. Every level of DyAnsys is committed to improving the quality of life of individuals, removing the burden of pain and allowing them to truly fulfil their potential. To ensure that this commitment is maintained across every aspect of the organization, only the highest quality manufacturing facilities in India are used, each meeting the exacting standards required in the US and Europe for medical manufacturing. Healthcare providers and patients have grown to trust the exceptional results from DyAnsys, as the team aims to provide the best possible care. At the heart of every decision made by DyAnsys is their intimate knowledge of the ANS. It’s fundamental to everything that the firm provides, with their diagnostic products designed to precisely measure the ANS and reduce dysfunction. The products that DyAnsys have developed are designed not only to work within a doctor’s office, but in the day-to-day life of an ordinary patient. By always working to ensuring that this treatment available for all, the company has grown its customer base, while also promoting the value of the ANS. Exploring ways of providing affordable and effective treatment solutions for chronic pain has always been a major factor at DyAnsys, and one of the most exciting developments has come from investigating vagal stimulation. This process revolves around providing electrical impulses to the vagus nerve. Going beyond the short-term solutions that many others offer, the team at DyAnsys has developed and produced their own method of treatment. Non-narcotic, with minimal side effects, the Primary Relief® is a wearable device that adopts the principle of auricular neurostimulation therapy. The device is designed to administer continuous pulses of a low-level electrical current through the ear over several days. Using research that goes from to the 1950s to the present day, the team have discovered that their device is able to reduce the symptoms of chronic pain and depression thanks to the stimulation and release of endorphins. When it comes to pain relief, it’s no wonder that this approach, using the body’s own chemical reactions, has proven to be so successful. In short, the team at DyAnsys have made the world of pain relief their oyster. Instead of focusing on the medical world, their products are specifically designed to be used by normal people going through everyday crisis. With over 100 million American adults estimated to suffer from chronic pain, it’s a solution that has been a long time in the making. It’s also a solution that, now perfected, could transform millions of lives. Company: DyAnsys Contact: Srini Nageshwar Web Address: www.dyansys.com